How U.S. court secrecy hobbles regulators meant to protect the public
When judges seal evidence about defective cars, drugs and other products, the watchdogs that could take life-saving action are sometimes left in the dark.
Related Articles
In ageing Japan, investor Orbis sees big growth potential for drugstores
The prospect of more consolidation among Japan’s fragmented drugstore industry is likely to boost the longer term value of major players, the Japan chief of…
J&J sues in latest bid to halt Medicare drug price negotiations
Johnson & Johnson sued the U.S. government on Tuesday, becoming the latest drugmaker seeking to block a program that gives the Medicare government health insurance…
Pfizer, Flagship Pioneering to invest $100 mln in drug discovery
U.S. drugmaker Pfizer and venture firm Flagship Pioneering on Tuesday said they would invest $100 million together to develop up to 10 new potential drugs…
The health risks of extreme heat
The world is baking under extreme heat – with Asia, Europe and the United States all dealing with scorching temperatures.
Teladoc expands Microsoft tie-up to document patient visits with AI
Teladoc Health is expanding a partnership with Microsoft to use the tech giant’s artificial intelligence services to automate clinical documentation on the telehealth platform, lifting…
Novartis raises 2023 forecast, maps out Sandoz spin-off
Novartis on Tuesday raised its full-year earnings forecast for the second time on strong drug sales and mapped out the planned separation and stock market…
Pfizer, Flagship Pioneering to invest $100 mln for drug discovery
U.S. drugmaker Pfizer and venture capital firm Flagship Pioneering on Tuesday agreed to invest $100 million to discover and develop 10 new potential drugs targeting…
US FDA approves Sanofi-AstraZeneca’s preventive RSV therapy for babies
The U.S. Food and Drug Administration (FDA) said on Monday it had approved Sanofi and partner AstraZeneca’s antibody therapy to prevent respiratory syncytial virus (RSV)…
Medical gear maker Getinge’s core profit halves on quality and supply issues
Medical equipment maker Getinge on Tuesday reported a sharp drop in second-quarter core profit, hit by quality and supply chain problems in its Cardiac Assist…
Novartis raises 2023 forecast, maps out Sandoz spin-off
Novartis on Tuesday raised its full-year earnings forecast on strong drug sales and mapped out the planned separation and stock market debut of its generic…